financetom
Business
financetom
/
Business
/
Jeffrey Epstein had accounts with Goldman Sachs and HSBC, documents show
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Jeffrey Epstein had accounts with Goldman Sachs and HSBC, documents show
Nov 4, 2025 9:36 AM

NEW YORK, Nov 4 (Reuters) - Jeffrey Epstein, the

disgraced late financier and sex offender, had accounts at

Goldman Sachs ( GS ), HSBC ( HSBC ) and other banks, new court

filings show.

The revelations came in previously sealed documents made

public by JPMorgan Chase ( JPM ), once Epstein's main bank, in a

now-settled lawsuit brought by the U.S. Virgin Islands, where

Epstein had a private island residence.

Epstein is listed as having had a Goldman account and three

accounts with HSBC's ( HSBC ) private bank in Switzerland in a suspicious

activity report filed by JPMorgan ( JPM ) with the U.S. Treasury's

Financial Crimes Enforcement Network soon after he died.

Released to the public on Friday, the report did not provide

dollar amounts or details about Epstein's relationships with

other banks, but alerted authorities to money transfers he made.

A U.S. judge ordered the documents unsealed in response to

requests from The New York Times and The Wall Street Journal.

Bloomberg earlier reported the banks' names.

In an emailed statement, Goldman said: "We terminated our

client relationship with Mr. Epstein, and his assets were

transferred out of the firm in 2010."

HSBC ( HSBC ) declined to comment.

Epstein died by suicide in 2019 in a Manhattan jail while

awaiting trial on sex trafficking charges.

The circumstances of his death, and his relationships with

wealthy and powerful people, fueled theories that others may

have been involved in his crimes.

His case became a political headache for U.S. President

Donald Trump, who reneged on a pledge during his 2024 election

campaign to release Epstein-related files from a Department of

Justice investigation.

That prompted an outcry from Trump's conservative base,

including some members of Congress.

The House Committee on Oversight and Government Reform is

investigating the Epstein case.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Bausch Health's Xifaxan Patent Clarity, Policy Commentary in Focus for Q2, RBC Says
Bausch Health's Xifaxan Patent Clarity, Policy Commentary in Focus for Q2, RBC Says
Jul 15, 2025
11:40 AM EDT, 07/15/2025 (MT Newswires) -- Bausch Health's ( BHC ) potential updates on the patent infringement case regarding the Xifaxan drug and commentary on potential policy-related headwinds will be the key focus when the company publishes its Q2 earnings later this month, RBC Capital Markets said Tuesday. RBC expects the company to post Q2 revenue of $2.53 billion,...
Citigroup's Quarterly Results Beat Estimates Amid Trading, Investment Banking Gains
Citigroup's Quarterly Results Beat Estimates Amid Trading, Investment Banking Gains
Jul 15, 2025
11:39 AM EDT, 07/15/2025 (MT Newswires) -- Citigroup's ( C ) second-quarter results surpassed Wall Street's expectations, buoyed by trading gains and double-digit revenue growth in investment banking. Earnings per share rose to $1.96 from $1.52 a year earlier and exceeded the consensus on FactSet for $1.61. Revenue grew 8% to $21.67 billion, above the Street's estimate of $20.96 billion....
Jazz Pharmaceuticals Stock Offers Buying Opportunity After Slump, Deutsche Bank Says
Jazz Pharmaceuticals Stock Offers Buying Opportunity After Slump, Deutsche Bank Says
Jul 15, 2025
11:40 AM EDT, 07/15/2025 (MT Newswires) -- Jazz Pharmaceuticals' ( JAZZ ) stock offers an attractive entry point for investors following its recent decline with the outlook bolstered by expansion in the oncology business and resilience in neuroscience, Deutsche Bank said Tuesday in a note. The company will enter a period of value creation from H2 through 2027, driven by...
Copyright 2023-2026 - www.financetom.com All Rights Reserved